Risk Factors for Postoperative Complications in Major Non-cardiac Surgery: Post-hoc Analysis of the OPHIQUE Multicentre Study
MULTIPAS
1 other identifier
observational
350
1 country
1
Brief Summary
Post-operative morbidity and mortality is related to many factors related to the patient's condition, the intra-operative period and the optimisation of intra-operative haemodynamic and respiratory parameters. Many studies have looked at the determinants and factors that increase postoperative complications. However, these have been randomised studies looking at one parameter in particular. This analysis would be the first to investigate the determinants of postoperative complications in a large population of patients undergoing major non-cardiac surgery. This is a post-hoc analysis of patients included in the OPHIQUE study, whose main objective was to evaluate intraoperative haemodynamic management guided by a marker of tissue hypoperfusion (the respiratory quotient).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2022
CompletedFirst Submitted
Initial submission to the registry
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
April 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedApril 27, 2023
March 1, 2023
4 months
March 28, 2023
April 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
NUmber of risk factors associated with postoperative morbidity in major non-cardiac surgery
2 years
Number of risk factors associated with postoperative mortality in major non-cardiac surgery
2 years
Secondary Outcomes (1)
Number of risk factors associated with the occurrence of postoperative renal dysfunction.
2 years
Study Arms (2)
patients with complications
patients without complication
Eligibility Criteria
* Abdominal, orthopaedic or vascular surgery under general anaesthesia and with an estimated duration of surgery \> 2 hours * Adult patients (age ≥ 18 years) * ASA score ≥ II * Patient with at least two of the following comorbidities: age \> 50 years, high blood pressure (HTA), heart failure, ECG abnormality, smoking, stroke, transient ischemic attack (TIA), peripheral arterial disease (PAD), insulin-dependent or non-insulin-dependent diabetes mellitus (NIDDM), ascites, chronic renal failure (CRF)
You may qualify if:
- Abdominal, orthopaedic or vascular surgery under general anaesthesia and with an estimated duration of surgery \> 2 hours
- Adult patients (age ≥ 18 years)
- ASA score ≥ II
- Patient with at least two of the following comorbidities: age \> 50 years, high blood pressure (HTA), heart failure, ECG abnormality, smoking, stroke, transient ischemic attack (TIA), peripheral arterial disease (PAD), insulin-dependent or non-insulin-dependent diabetes mellitus (NIDDM), ascites, chronic renal failure (CRF)
- Signature of the consent form
- Affiliation to a social security scheme
You may not qualify if:
- Severe untreated or unbalanced hypertension
- Preoperative renal failure on dialysis
- Acute heart failure
- Acute coronary insufficiency
- Vascular surgery with renal plasty
- Cardiac surgery
- Permanent laparoscopy
- Chronic respiratory failure with home oxygen therapy
- Acute respiratory distress syndrome with FiO2\>60%.
- Preoperative shock
- Surgery under spinal anaesthesia and epidural only
- Refusal to participate by the patient
- Pregnant, parturient or breastfeeding women
- Patients under guardianship or curators, under court protection or deprived of public rights
- The patient already included in another therapeutic trial with an experimental molecule
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens-Picardie
Amiens, 80054, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2023
First Posted
April 21, 2023
Study Start
June 23, 2022
Primary Completion
October 21, 2022
Study Completion
July 1, 2023
Last Updated
April 27, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share